Search Results - "Sanz, Ramón. García"
-
1
Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemia
Published in British journal of haematology (01-06-2020)“…Summary Ibrutinib is highly active in Waldenström macroglobulinaemia (WM) patients, but disease progression can occur due to acquired mutations in BTK, the…”
Get full text
Journal Article -
2
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
Published in British journal of haematology (01-03-2021)“…Summary Deletion of the long arm of chromosome 6 (del6q) is the most frequent cytogenetic abnormality in Waldenström macroglobulinaemia (WM), occurring in…”
Get full text
Journal Article -
3
FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma
Published in Journal of cellular and molecular medicine (01-04-2020)“…FAM46C, frequently mutated in multiple myeloma (MM), has recently been shown to encode a non‐canonical poly(A) polymerase (ncPAP). However, its target mRNAs…”
Get full text
Journal Article -
4
Liquid biopsy: a non‐invasive approach for Hodgkin lymphoma genotyping
Published in British journal of haematology (01-11-2021)“…Summary The Hodgkin lymphoma (HL) genomic landscape is hardly known due to the scarcity of tumour cells in the tissue. Liquid biopsy employing circulating…”
Get full text
Journal Article -
5
Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem‐cell transplantation is a prognostic marker of longer progression‐free survival and overall survival
Published in British journal of haematology (01-07-2022)“…Summary Immunoparesis is the suppression of normal polyclonal immunoglobulins and is present in most patients with newly diagnosed multiple myeloma (MM). The…”
Get full text
Journal Article -
6
Time to Move to the Single-Cell Level: Applications of Single-Cell Multi-Omics to Hematological Malignancies and Waldenström's Macroglobulinemia-A Particularly Heterogeneous Lymphoma
Published in Cancers (26-03-2021)“…Single-cell sequencing techniques have become a powerful tool for characterizing intra-tumor heterogeneity, which has been reflected in the increasing number…”
Get full text
Journal Article -
7
Identification of the novel HLA‐A23:01:01:27 allele in an acute myeloid patient and related donor
Published in HLA (01-07-2022)“…A single nucleotide polymorphism in intron 1 determines the new HLA‐A*23:01:01:27 allele…”
Get full text
Journal Article -
8
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma
Published in American journal of hematology (01-06-2022)“…Loss and/or mutation of the TP53 gene are associated with short survival in multiple myeloma, but the p53 landscape goes far beyond. At least 12 p53 protein…”
Get full text
Journal Article -
9
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
Published in British journal of haematology (01-07-2024)“…Circulating tumour DNA (ctDNA) allows genotyping and minimal residual disease (MRD) detection in lymphomas. Using a next-generation sequencing (NGS) approach…”
Get full text
Journal Article -
10
Identification of relapse‐associated gene mutations by next‐generation sequencing in low‐risk acute myeloid leukaemia patients
Published in British journal of haematology (01-05-2020)“…Summary Recommended genetic categorization of acute myeloid leukaemias (AML) includes a favourable‐risk category, but not all these patients have good…”
Get full text
Journal Article -
11
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group
Published in British journal of haematology (01-02-2021)“…Summary This phase I/II trial evaluated the combination of the kinesin spindle protein inhibitor filanesib with pomalidomide and dexamethasone in relapsed or…”
Get full text
Journal Article -
12
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
Published in Hematological oncology (01-10-2023)“…While some follicular lymphoma (FL) patients do not require treatment or experience prolonged responses, others relapse early, and little is known about…”
Get full text
Journal Article -
13
Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression
Published in Clinical chemistry and laboratory medicine (28-08-2017)“…The management of IgM monoclonal gammopathies undetermined significance (IgM-MGUS) and Waldenstrom's macroglobulinemia (WM) may be challenging. Modern…”
Get more information
Journal Article -
14
Zebularine-induced myeloma cell death is accompanied by decreased c-Myc expression
Published in Cellular oncology (Dordrecht) (01-08-2020)“…Purpose Epigenetic therapies have proven to be clinically effective in several hematological malignancies. Here, we aimed to evaluate the effect of a…”
Get full text
Journal Article -
15
Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results
Published in HemaSphere (01-04-2024)Get full text
Journal Article -
16
Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy
Published in British journal of haematology (01-09-2016)“…Summary The management of recurrent/refractory (R/R) Hodgkin lymphoma (HL) remains challenging. Previously published data have shown some efficacy of rituximab…”
Get full text
Journal Article -
17
-
18
Exportin‐1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma
Published in Hematological oncology (01-04-2019)Get full text
Journal Article -
19
Identification of miRSNPs associated with the risk of multiple myeloma
Published in International journal of cancer (01-02-2017)“…Multiple myeloma (MM) is a malignancy of plasma cells usually infiltrating the bone marrow, associated with the production of a monoclonal immunoglobulin (M…”
Get full text
Journal Article -
20
The combination of bortezomib and dexamethasone is an efficient therapy for relapsed/refractory scleromyxedema: a rare disease with new clinical insights
Published in European journal of haematology (01-05-2012)“…Scleromyxedema (SM) is a rare primary cutaneous inflammatory mucinosis characterised by papular mucinosis, monoclonal gammopathy and extracutaneous…”
Get full text
Journal Article